fda warning compounding semaglutide october 2025 Patient Safety Updates September 8, 2025: FDA launches

Furthermore, pharmacoepidemiological studies have examined electronic health records to explore associations between GLP-1RAs prescriptions and alcohol-related outcomes

Negative reviews frequently report skin irritation, rashes, blisters, and no change in weight

Some people also consider the switch after researching the triple-receptor advantage and deciding they want to try a broader approach to metabolic health

"For patients who didn't do psychological work alongside the medicine, this is the worst-case convergence that tends to produce the most distress and the most rapid regain," he says

E., Javaid, M

Go deeper: WBUR's Maddie Browning spoke to Oppong-Yeboah about what they hope to accomplish during their four-year term, which begins in July